Neil F. McFarlane

Companies

• ZEVRA THERAPEUTICS, INC.Board member Oct 10, 2023 to now¹
• ZEVRA THERAPEUTICS, INC.Chief executive officer Oct 10, 2023 to now¹
• ZEVRA THERAPEUTICS, INC.President Oct 10, 2023 to now¹
• COLLEGIUM PHARMACEUTICAL, INCBoard member Apr 8, 2022 to May 16, 2024²
• Adamas Pharmaceuticals (United States)Board member Nov 24, 2021 to Nov 24, 2021³
• Adamas Pharmaceuticals (United States)Chief executive officer Sep 17, 2019 to Nov 24, 2021⁴
• Travere Therapeutics, Inc.Chief operating officer Aug 15, 2016 to May 16, 2019⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ZTZEVRA THERAPEUTICS, INC. ZVRA387,225 shares⁶$3.9M at $10.17Feb 9, 2026
• CPCOLLEGIUM PHARMACEUTICAL, INC COLL49,365 shares⁷$1.2M at $23.45May 16, 2024
• APAdamas Pharmaceuticals (United States)0 shares⁸Nov 24, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 9, 2026Sold 14,625 shares at $8.56 of ZEVRA THERAPEUTICS, INC.⁶
• Feb 7, 2026Exercised options 37,500 shares of ZEVRA THERAPEUTICS, INC.⁶
• Feb 2, 2026Sold 91,000 shares at $9.38 of ZEVRA THERAPEUTICS, INC.⁹
• Jan 31, 2026Exercised options 233,334 shares of ZEVRA THERAPEUTICS, INC.⁹
• Oct 10, 2025Sold 19,500 shares at $10.82 of ZEVRA THERAPEUTICS, INC.¹⁰
• Oct 10, 2025Exercised options 50,000 shares of ZEVRA THERAPEUTICS, INC.¹⁰
• Feb 14, 2025Sold 30,544 shares at $8.05 of ZEVRA THERAPEUTICS, INC.¹¹
• Feb 13, 2025Sold 61,273 shares at $7.86 of ZEVRA THERAPEUTICS, INC.¹¹
• Jan 31, 2025Exercised options 233,333 shares of ZEVRA THERAPEUTICS, INC.¹²
• May 16, 2024Granted 7,693 shares of COLLEGIUM PHARMACEUTICAL, INC⁷
• May 18, 2023Granted 9,792 shares of COLLEGIUM PHARMACEUTICAL, INC¹³
• May 19, 2022Granted 14,035 shares of COLLEGIUM PHARMACEUTICAL, INC¹⁴
• Apr 6, 2022Granted 17,845 shares of COLLEGIUM PHARMACEUTICAL, INC¹⁵
• Nov 24, 2021U 600,000 shares of Adamas Pharmaceuticals (United States)⁸
• Nov 24, 2021Granted 75,000 shares of Adamas Pharmaceuticals (United States)⁸